$PS

PERSHING SQUARE INC.

AlphAI earnings readSecond Quarter 2026 · AUG 12Pershing Square Inc. Reports Second Quarter 2026 ResultsVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
3
1

No SEC Form 4 filings for $PS in the last 30 days.

See all $PS insider activity →
Med

Pershing Square (PS) Declares Its Q4 2026 Dividend, Is The Stock Now Pricey?

Pershing Square (PS) declared a Q4 2026 dividend of $0.103 per share. The stock has seen significant gains, with a 30-day return of 50.1%, 90-day return of 66.1%, and year-to-date return of 142.4%. The company's fair value is estimated at $53, suggesting it may be overvalued at its current price of $58.65. Pershing Square plans to use modest leverage to scale exposure to its holdings.

10.3 cents per share is due to Pershing Square shareholders Oct. 20.

Pershing Square (PS) declared a $0.103 per share dividend for Q4 2026, payable on October 20. The company noted that future dividends are at the board's discretion and may vary or be discontinued. Pershing Square is the parent of Pershing Square Capital Management, an investment adviser based in New York.

PS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning PS (PERSHING SQUARE INC.). Coverage has skewed bearish: 0 bullish, 3 neutral, and 1 bearish.

Recent PS coverage spans corporate actions, market movers and earnings.

What's driving PS

AlphAI scores every news story that mentions PS with an AI model for sentiment and relevance, and aggregates insider trades from PERSHING SQUARE INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PS

Score
$PSMed

Pershing Square (PS) Declares Its Q4 2026 Dividend, Is The Stock Now Pricey?

Pershing Square (PS) declared a Q4 2026 dividend of $0.103 per share. The stock has seen significant gains, with a 30-day return of 50.1%, 90-day return of 66.1%, and year-to-date return of 142.4%. The company's fair value is estimated at $53, suggesting it may be overvalued at its current price of $58.65. Pershing Square plans to use modest leverage to scale exposure to its holdings.

Here Are Friday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Cerebras Systems, Coinbase Global, Edison International, Northrop Grumman, Pershing Square, Robinhood Markets, and More

Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Abbott Laboratories (ABT) was upgraded to Buy with a $127 target, Airbnb (ABNB) to Overweight with a $191 target, and Cerebras Systems (CBRS) to Buy with a $209 target. Downgrades included Edison International (EIX) to Underperform with a $42 target and Northrop Grumman (NOC) to Sector Perform with a $525 target. Coinbase Global (COIN) was initiated with an Equal Weight rating and a $200 target.

$PSLow

Pershing Square (PS) Stock Surges 5% as Ackman Launches Private Markets Initiative

Pershing Square (PS) shares rose 5% to $59.18 on September 28, extending a 49% rally since mid-September. The firm beat earnings estimates with $0.14 EPS and $68.03M revenue. It launched Pershing Square Ventures (PSV), a new private markets initiative, after drawing $30M from its credit facility. Assets under management reached $33B, with $54.18M in Q2 management fees. Analysts average a $41-$42 price target, leaning toward Hold.

Bill Ackman's Pershing Square Swaps Alphabet for Meta in High-Stakes AI Pivot

Bill Ackman's Pershing Square sold its Alphabet stake and increased its Meta position by 20%. Meta's stock rose 19% since June, driven by its AI product Muse, while Alphabet faced antitrust challenges and high capital spending. Meta's Q2 revenue grew 28% YoY to $60.8B. Analysts see potential in both stocks but highlight Meta's valuation discount and Muse's revenue potential.

Related tickers